PKU HealthCare Corp.,Ltd. (SHE:000788)
5.48
-0.15 (-2.66%)
Sep 10, 2026, 3:04 PM CST
PKU HealthCare Corp.,Ltd. Revenue
PKU HealthCare Corp.,Ltd. had revenue of 231.94M CNY in the quarter ending June 30, 2026, a decrease of -49.02%. This brings the company's revenue in the last twelve months to 972.17M, down -51.61% year-over-year. In the year 2025, PKU HealthCare Corp.,Ltd. had annual revenue of 1.48B, down -28.04%.
Revenue (ttm)
972.17M
Revenue Growth
-51.61%
P/S Ratio
3.45
Revenue / Employee
1.23M
Employees
789
Market Cap
3.36B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.48B | -577.64M | -28.04% |
| Dec 31, 2024 | 2.06B | -133.78M | -6.10% |
| Dec 31, 2023 | 2.19B | 116.44M | 5.61% |
| Jan 1, 2023 | 2.08B | -159.42M | -7.13% |
| Jan 1, 2022 | 2.24B | 259.35M | 13.12% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Nanjing Well Pharmaceutical Group | 1.40B |
| Huaren Pharmaceutical | 1.30B |
| Anhui Sunhere Pharmaceutical Excipients | 993.60M |
| Zhejiang Cheng Yi Pharmaceutical | 827.47M |
| Tibet AIM Pharm. | 684.45M |
| Wuhan Hiteck Biological Pharma Co.,Ltd | 491.90M |
| Honz Pharmaceutical | 378.56M |
| Hainan Shuangcheng Pharmaceuticals | 309.80M |